Clinical trial Recruiting at 1 site Observational

Can pre-surgery lean (fat-free) mass predict weight loss after Roux-en-Y gastric bypass?

Official title: Can Pre-operative Lean Mass Predict Weight Loss After Roux-en-Y Gastric Bypass?

Run by University Hospital, Geneva · NCT07565051 · Data updated 2026-11-12

This project will see if the amount of lean (fat-free) mass before surgery predicts how much weight people with morbid obesity lose in the two years after Roux-en-Y gastric bypass.

More Morbid Obesity Requiring Bariatric Surgery trials

Quick facts

Study typeObservational
SexAll
Enrollment91 (estimated)
SponsorUniversity Hospital, Geneva
Academic / other
Locations1 site (Geneva, Canton of Geneva)
StatusRecruiting
StartedAugust 18, 2025
Main results expectedAugust 18, 2027
Study endsAugust 18, 2032
Registry record updatedMay 8, 2026
Trial IDNCT07565051 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) who meet Swiss criteria for Roux-en-Y gastric bypass (BMI≥35 with prior weight-loss program failure or higher BMI criteria), are scheduled for or previously had RYGB at Geneva University Hospitals with follow-up there, can consent and understand French.

Probably not a fit

People who are not having RYGB, who cannot consent, who plan a different bariatric procedure, or who have contraindications such as active cancer, severe psychiatric disease, substance abuse, or advanced kidney failure are unlikely to benefit from the study's findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective observational cohort (with retrospective data included) of adults undergoing or previously treated with Roux-en-Y gastric bypass at Geneva University Hospitals. Investigators will measure preoperative body composition (BIA and DXA), handgrip strength, resting energy expenditure, eating and activity questionnaires, clinical labs, and routinely collected anthropometrics. These measures and questionnaires will be repeated at scheduled follow-ups up to two years after surgery, and blood/tissue samples will be banked. The primary analysis will correlate preoperative fat-free mass with weight change over the two-year postoperative period.

Why it matters

Potential benefit: If successful, the results could help personalize preoperative counseling and postoperative nutrition/rehabilitation to improve weight-loss outcomes.

How similar studies have gone: Prior observational work on preoperative lean mass as a predictor of bariatric weight loss has produced mixed results, so this approach builds on existing but inconsistent evidence rather than being wholly novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients ≥ 18 years AND
* Meeting inclusion criteria for RYGB (www.smob.ch): BMI ≥35 kg/m2, failure of weight-reducing programs over 2 years (for patients with a BMI ≥50 kg/m2, 1 year), understanding of the necessity to change the lifestyle and eating habits post-operatively, signed consent for lifelong post-operative follow-up in a recognized bariatric center AND
* Scheduled RYGB at the HUG OR previous RYGB at the HUG with a present follow-up in Clinical Nutrition and dietetics at the HUG AND
* Understanding French

Exclusion Criteria:

* Inability or refusal to give consent.
* Planification for another type of bariatric surgery than RYGB
* Contra-indications to bariatric surgery as stated under www.smob.ch: insufficient nutritional knowledge in nutrition to lose weight, pregnancy, kidney failure (Creatinine ≥ 300 umol/l without dialysis, Crohn's disease, active cancer or remission \< 2 years, active psychiatric disease, substance abuse (alcohol, cannabis, opioids), absence of compliance, lack of understanding of the requirements and necessary lifestyle changes reported by physician or dietician.

Where it's running

  • Geneva University Hospitals
    Geneva, Canton of Geneva, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.